Madeline Colli is a journalist specializing in cannabis science and technology. With a focus on local stories in the United States, particularly in Missouri and Kansas City, Madeline covers topics related to medical cannabis, legislation, industry trends, and the impact of cannabis on communities. Through her articles, she aims to provide informative and insightful content that empowers readers with knowledge about this rapidly evolving field.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Madeline Colli's coverage primarily focuses on the cannabis industry, with an emphasis on local news related to Missouri and Kansas City. She is particularly interested in expert commentary and government announcements within the healthcare, scientific, and business sectors as they relate to cannabis.
Given her focus on localized cannabis-related stories and expert commentary, she would likely be interested in hearing from professionals involved in medical or scientific research pertaining to cannabis use. Additionally, individuals well-versed in local legislative developments around cannabis legalization could also provide valuable insights for her articles.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Madeline Colli
Leah Sera, PharmD, MA, the co-program director for the University of Maryland School of Pharmacy’s Graduate Studies in Medical Cannabis program sat down with Cannabis Science and Technology to discuss higher education in medical cannabis.
By: Madeline Colli
Products containing Delta-8 THC may be leading to an increase in calls to poison control centers, according to a recent study.
By: Madeline Colli, Erin Mcevoy
In this interview, we discuss the potential of cannabinoids in treating common health conditions in pets.
By: Madeline Colli
Vice President Kamala Harris unveiled her cannabis legalization plan as part of her 2024 presidential campaign.
By: Erin Mcevoy, Madeline Colli
MM411’s president and co-founder, Chris DeVol, discusses the evolution of the company, their most popular cannabis education courses, and their partnership with Cannabis Science and Technology.
By: Madeline Colli, Erin Mcevoy
MM411’s president and co-founder, Chris DeVol, discusses challenges and trends in global cannabis education, plus upcoming initiatives of the company.
By: Erin Mcevoy, Madeline Colli
On November 5, 2024, Floridians will decide on Amendment 3, which proposes legalizing recreational cannabis. Former President Trump has stated support for this measure, aligning with his stance on state-level cannabis policies.
By: Madeline Colli, Erin Mcevoy
With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election. We discuss what drives support or opposition from both sides of the aisle, the complexities of balancing state and federal priorities, and more. Join us in the first part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
By: Erin Mcevoy, Madeline Colli
As bat guano becomes more commonly used in cannabis cultivation, a recent study highlights the negative effects that can come with using this type of fertilizer.
By: Madeline Colli
The Clean Label Project released a new report where they announced findings of lead and cadmium in protein powders.
(833) 317-6278 